Top Markets
Coin of the day
AIM ImmunoTech Inc. AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIM
Clasificación en acciones #38739
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida,... AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
Precio por acción
$0.2443
Capitalización bursátil
$831.49K
Cambio (1 día)
-5.42%
Cambio (1 año)
-89.90%
País
US
Comercio AIM ImmunoTech Inc. (AIM)

Categoría

Precio AIM con Capital del mercado a B
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
AIM
$0.2443
Capitalización de mercado de AIM ImmunoTech Inc.(AIM)
Capitalización bursátil: $831.49K
A fecha de August 2026, AIM ImmunoTech Inc. tiene una capitalización de mercado de $831.49K. Esto convierte a AIM ImmunoTech Inc. en la 38739th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de AIM ImmunoTech Inc. desde 1996 hasta 2026
AIM en comparación con los más populares 5 títulos stocks
Precio por AIM Activo B Capital del mercado en B Resultados
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,602,232 $831.49K
$5.453T +655,846,058.79%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,318,718 $831.49K
$4.488T +539,794,367.38%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,222,597 $831.49K
$4.161T +500,448,998.04%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$1,086,592 $831.49K
$3.698T +444,777,489.63%
AIM ImmunoTech Inc. AIM ImmunoTech Inc.
$833,093 $831.49K
$2.835T +341,012,011.66%